Gan & Lee Pharmaceuticals

Founded in 1998, Gan & Lee Pharmaceuticals (hereinafter referred to as Gan & Lee, stock code: 603087.SH) is a leading pharmaceutical company in China, specializing in the development, production, and commercialization of insulin analogs and medical devices. Headquartered in Beijing, Gan & Lee has an industrial park of about 200,000 square meters. The company has more than 5,000 employees globally. Gan & Lee developed the first Chinese domestic insulin analog and currently has a series of insulin products approved in China. Moreover, Gan & Lee concluded a commercialization and supply agreement with Sandoz to expand developed markets. As a global company focusing on the health of human beings, Gan & Lee is committed to providing scientific solutions to patients across the globe to have a positive impact on patient lives.